Remove Clinical Practice Remove Complication Remove Healthcare Professional Remove Referral
article thumbnail

Dysphagia Revisited: A Podcast with Raele Donetha Robison and Nicole Rogus-Pulia

GeriPal

Eric: And swallowing is complicated, right? So, if it’s a hospitalized patient, usually the referral will come through to the SLP service. So, the consult will come in and then we’ll do what we call a clinical bedside evaluation, where we’ll go and see the patient at the bedside. Nicole: Yes. Nicole: Exactly.

IT 124
article thumbnail

What You Should Know About Radiation Oncology: Anish Butala, Emily Martin and Evie Kalmar

GeriPal

And sort of a few years ago, we would sometimes see referrals a bit later than we would have liked. We are Seeing referrals at an earlier time point, especially at a point that I feel that I can really help a patient. Is it normally the oncologist who’s making the referrals to you or do they come from people outside of oncology?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Dignity at the End of Life: A Podcast with Harvey Chochinov

GeriPal

Had multiple physical, psychological complications as a result of that. How do you do that in clinical practice, in a way that doesn’t take five hours of sitting down with somebody? So I mean, I had referrals from as far as Canadian Arctic North, of people who were interested in doing dignity therapy.

article thumbnail

Pragmatic Trial of ACP: Jennifer Wolff, Sydney Dy, Danny Scerpella, and Jasmine Santoyo-Olsson

GeriPal

Summary Transcript CME Summary A pragmatic trial evaluates the effectiveness of a treatment or intervention in real-world clinical practice. But the process of implementing this project across two big health systems in our area was very complicated and had its share of both challenges and rewards. We were agnostic on the timing.

article thumbnail

Sexual Function in Serious Illness: Areej El-Jawahri, Sharon Bober, and Don Dizon

GeriPal

Don 13:50 Well, you know, I think one of the issues, though, when you ask about prevalence data, especially, say, in the oncology world, not only does it matter about how you ask the questions, but because it’s such a complicated topic, people may infer very different things as to what you’re talking about. Sharon 15:21 Right.

Illness 130